Inovio stock rise highlights the impact of plasmid DNA drug approval on market performance.
Read MoreInovio stock rise highlights the impact of plasmid DNA drug approval on market performance.
Read MoreExpired Covid-era approvals are under fire as SC slams the Centre and drug regulator for negligence in antifungal drug approvals.
Read More